Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bioman1
    Member
    • May 2012
    • 80

    #1

    Improving assembly with PacBIo

    We have one paired-end (2x 101 bp)libray Whole gnome short sequence (WGS) sequenced through illumina hiseq 2000. We have assembled genome assembly with Abyss software. The assembly has lower N50 value around 1Kbp and does not improve in scaffolding because we have only one paired-end libarary. The estimated insert size is around 240 bp and coverage is arond 5x. Our sequenced plant is a polyploid, we lack data in getting good draft assembly and as we have budget constraint, we cannot go for additional illumina paired-end sequencing. But we some budget for 1x pacBio sequencing. My question does 1x pacBio sequencing helps in improving assembly atleast to get organelle genomes.
  • gconcepcion
    Member
    • Dec 2010
    • 68

    #2
    Originally posted by bioman1 View Post
    We have one paired-end (2x 101 bp)libray Whole gnome short sequence (WGS) sequenced through illumina hiseq 2000. We have assembled genome assembly with Abyss software. The assembly has lower N50 value around 1Kbp and does not improve in scaffolding because we have only one paired-end libarary. The estimated insert size is around 240 bp and coverage is arond 5x. Our sequenced plant is a polyploid, we lack data in getting good draft assembly and as we have budget constraint, we cannot go for additional illumina paired-end sequencing. But we some budget for 1x pacBio sequencing. My question does 1x pacBio sequencing helps in improving assembly atleast to get organelle genomes.
    With only 5x short read data, it is highly unlikely that 1x PacBio will improve any polyploid assembly, let alone a plant genome which is almost certainly highly repetitive.

    If organellar genome is all you are interested in, you would be better off harvesting and concentrating the plastids using a cell sorter and subsequently sequencing the DNA extracted from the sorted organelles with PacBio

    Comment

    • rhall
      Senior Member
      • Aug 2012
      • 324

      #3
      1x of PacBio will do absolutely nothing to improve the assembly, the minimum coverage would be ~10x for assembly improvement (gap filling / scaffolding). Even then, given that your illumina assembly is essentially not assembling (1kb N50 is significantly lower than a pacbio read length N50) it is highly unlikely that anything would be improved.
      For a draft plant assembly there are no budget options, do you already have transcript data? it is generally much more cost effective for large genomes. Or as the previous poster points out, if you can reduce the problem (isolate organelles) and get higher coverage either for illumina or PacBio then an assembly will be much more successful.

      Comment

      • Chipper
        Senior Member
        • Mar 2008
        • 323

        #4
        Well given the length of PacBio reads it would be hard not to improve the assembly even with 1x coverage since many of the small contigs will be attracted by single long reads. If your budget was calculated some time ago it might be that you can get substantially higher coverage given that it nov can give ~1 Gb per cell. Not saying that low coverage illumina + low coverage pacbio will give you a good assembly though.

        Comment

        • rhall
          Senior Member
          • Aug 2012
          • 324

          #5
          The problem is that there is a low, but nonzero chance of a single read being chimeric (blunt end ligation of adapters can also result in blunt end ligation of fragments), therefore without multiple observations it is impossible to validate the long range information in a single read.

          Comment

          • bioman1
            Member
            • May 2012
            • 80

            #6
            Thank you for all replying. If I have 1x PacBio, does it help to map my illumina reads and I have some transcriptome dataset to this PacBio assembly and get organelle contigs (mitochondria and chloroplast). It will any form of information?

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
              by SEQadmin2



              CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

              Despite this, “CRISPR helped turn genome editing from a specialized technique into
              ...
              07-31-2026, 11:01 AM
            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Today, 07:41 AM
            0 responses
            9 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-03-2026, 10:13 AM
            0 responses
            24 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-31-2026, 02:55 AM
            0 responses
            38 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            25 views
            0 reactions
            Last Post SEQadmin2  
            Working...